Literature DB >> 8721363

[A case of a patient with post-operative empyema due to Mycobacterium chelonae].

N Takemoto1, R Kohiyama, J Tsuboi, K Sasaki, I Sakurabayashi, M Miyata.   

Abstract

We reported a case of a thoracic empyema due to M. chelonae (Atypical Mycobacterium, group IV) after thoracic surgery. A 49-year-old male underwent right middle lobectomy for pulmonary metastasis of esophageal cancer. Postoperative course was complicated for intractable air leakage, and several procedures were tried before successful re-thoractomy. Seven days after re-thoractomy, mycobacterium was proved in pleural effusion. And later on M. chelonae was identified by DNA hybridization method. Therefore, open window thoracotomy was performed at once. M. chelonae disappeared 7 days after operation and the patient discharged on 40 postoperative days. Thoracic empyema by M. chelonae is rare, and only one case was reported in Japan so far. Present case was not combined with infectious pulmonary disease by some mycobacterium. Therefore it is most reasonable to suppose this intrathoracic infection developed through the thoracic drain. In conclusion, because of the M. chelonae toleranced for almost all anti-biotics including anti-tuberculous agents, except clarithromycin, the timing of surgical approach is important for the treatment of this infectious disease.

Entities:  

Mesh:

Year:  1996        PMID: 8721363

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  2 in total

1.  A novel therapeutic strategy to close bronchopleural fistula related to Mycobacterium chelonae in elderly patients: two case reports and literature review.

Authors:  Xiaolong Liu; Zhihua Huang; Shaohua Luo; Shifang Yang; Junwei Huang; Pingping Chen; Qi Lin; Jian Wu
Journal:  Ann Transl Med       Date:  2022-05

2.  Successful Treatment of a Renal Abscess Caused by Mycobacterium chelonae: A Case Report.

Authors:  Elizabeth Verghese; Ahmad Jabri; Richard R Watkins
Journal:  Open Forum Infect Dis       Date:  2018-08-16       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.